Current Use of Magnetic Resonance Imaging in Cardiology

Česká verzia

Authors: M. Solař ¹; J. Žižka ²; L. Klzo ²; J. Ceral ¹
Authors place of work: I. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jan Vojáček, DrSc. ¹; Radiologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Pavel Eliáš, CSc. ²
Published in the journal: Vnitř Lék 2008; 54(2): 183-190
Category: Review

Summary

Magnetic resonance is a modern imaging technique that is characterized by high resolution and variable tomographic slices. The development of magnetic resonance technology in last decade led to the expansion of this method in many fields of medicine. In cardiology, the imaging is focused on the heart, aorta, pulmonary, coronary and renal arteries. Dynamic imaging is used for the evaluation of the kinetics and the function of the ventricles. Static imaging serves for the assessment of the myocardial wall in patients with cardiomyopathies and coronary artery disease. The quality of static imaging can improve paramagnetic contrast agent that increasingly accumulates in areas of acute necrosis, fibrosis or infiltration of the myocardium. Magnetic resonance can also diagnose intracardiac tumors and thrombi, valvular heart disease and pericardial disorders. Despite of wide spectrum of diagnostic applications, the clinical use of magnetic resonance imaging is reduced by limited availability and high cost of the examination.

Key words:
magnetic resonance imaging - cardiology

Zdroje

1. Anbarasu A, Harris PL, McWilliams RG. The role of gadolinium-enhanced MR imaging in the preoperative evaluation of inflammatory abdominal aortic aneurysm. Eur Radiol 2002; 12(Suppl 3): S192-S195.

2. Assomull RG, Prasad SK, Lyne J et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985.

3. Baer FM, Voth E, LaRosee K et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996; 78: 415-419.

4. Bellenger NG, Burgess MI, Ray SG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000; 21: 1387-1396.

5. Caruthers SD, Lin SJ, Brown P et al. Practical Value of Cardiac Magnetic Resonance Imaging for Clinical Quantification of Aortic Valve Stenosis: Comparison With Echocardiography. Circulation 2003; 108: 2236-2243.

6. Cesare ED, Giordano AV, Cerone G et al. Comparative evaluation of TEE, conventional MRI and contrast-enhanced 3D breath-hold MRA in the post-operative follow-up of dissecting aneurysms. Int J Card Imaging 2000; 16: 135-147.

7. Corrado D, Fontaine G, Marcus FI et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation 2000; 101: E101-E106.

8. Dickfeld T. Magnetic Resonance Imaging and radiofrequency ablations. Herzschrittmacherther Elektrophysiol 2007; 18: 147-156.

9. Djavidani B, Debl K, Lenhart M et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 2048-2053.

10. Dulce MC, Mostbeck GH, O’Sullivan M et al. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992; 185: 235-240.

11. Fenster BE, Chan FP, Valentine HA et al. Images in cardiovascular medicine. Cardiac magnetic resonance imaging for myocarditis: effective use in medical decision making. Circulation 2006; 113: e842-e843.

12. Gerber BL, Garot J, Bluemke DA et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002; 106: 1083-1089.

13. Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90: 29-34.

14. Grothues F, Moon JC, Bellenger N et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004; 147: 218-223.

15. Hendrick RE. The AAPM/RSNA physics tutorial for residents. Basic physics of MR imaging: an introduction. Radiographics 1994; 14: 829-846.

16. Herborn CU, Watkins DM, Runge VM et al. Renal arteries: comparison of steady-state free precession MR angiography and contrast-enhanced MR angiography. Radiology 2006; 239: 263-268.

17. Hundley WG, Li HF, Lange RA et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation 1995; 91: 2955-2960.

18. Ingkanisorn WP, Kwong RY, Bohme NS et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006; 47: 1427-1432.

19. Kersting-Sommerhoff BA, Diethelm L, Stanger P et al. Evaluation of complex congenital ventricular anomalies with magnetic resonance imaging. Am Heart J 1990; 120: 133-142.

20. Kim HW, Klem I, Kim RJ Detection of myocardial ischemia by stress perfusion cardiovascular magnetic resonance. Cardiol Clin 2007; 25: 57-70.

21. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.

22. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345: 1863-1869.

23. Kizilbash AM, Hundley WG, Willett DL et al. Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. Am J Cardiol 1998; 81: 792-795.

24. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105: 162-167.

25. Kupfahl C, Honold M, Meinhardt G et al. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart 2004; 90: 893-901.

26. Kwong RY, Chan AK, Brown KA et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113: 2733-2743.

27. Mahrholdt H, Wagner A, Judd RM et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002; 23: 602-619.

28. Malyar NM, Schlosser T, Buck T et al. Using cardiac magnetic resonance tomography for assessment of aortic valve area in aortic valve stenosis. Herz 2006; 31: 650-657.

29. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992; 182: 369-373.

30. McCrohon JA, Moon JC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59.

31. Moon JC, Fisher NG, McKenna WJ et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004; 90: 645-649.

32. Moon JC, McKenna WJ, McCrohon JA et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-1567.

33. Moon JC, Sachdev B, Elkington AG et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003; 24: 2151-2155.

34. Nagel E, Lehmkuhl HB, Bocksch W et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770.

35. Nazarian S, Roguin A, Zviman MM et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114: 1277-1284.

36. Omran H, Schmidt H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361: 1241-1246.

37. Pennell DJ, Sechtem UP, Higgins CB et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004; 25: 1940-1965.

38. Perugini E, Rapezzi C, Piva T et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006; 92: 343-349.

39. Raman VK, Lederman RJ. Interventional cardiovascular magnetic resonance imaging. Trends Cardiovasc Med 2007; 17: 196-202.

40. Sahn DJ, Vick GW 3rd. Review of new techniques in echocardiography and magnetic resonance imaging as applied to patients with congenital heart disease. Heart 2001; 86(Suppl 2): II41-II53.

41. Schuijf JD, Bax JJ, Shaw LJ et al. Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J 2006; 151: 404-411.

42. Schwitter J, Nanz D, Kneifel S et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001; 103: 2230-2235.

43. Sechtem U, Pflugfelder PW, Cassidy MM et al. Mitral or aortic regurgitation: quantification of regurgitant volumes with cine MR imaging. Radiology 1988; 167: 425-430.

44. Semelka RC, Shoenut JP, Wilson ME et al. Cardiac masses: signal intensity features on spin-echo, gradient-echo, gadolinium-enhanced spin-echo, and TurboFLASH images. J Magn Reson Imaging 1992; 2: 415-420.

45. Shimada T, Shimada K, Sakane T et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-527.

46. Spuentrup E, Katoh M, Buecker A et al. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Invest Radiol 2007; 42: 586-595.

47. Srichai MB, Junor C, Rodriguez LL et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006; 152: 75-84.

48. Stork A, Muellerleile K, Bansmann PM et al. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. Eur Radiol 2007; 17: 610-617.

49. Takahashi N, Inoue T, Oka T et al. Diagnostic use of T2-weighted inversion-recovery magnetic resonance imaging in acute coronary syndromes compared with 99mTc-Pyrophosphate, 123I-BMIPP and 201TlCl single photon emission computed tomography. Circ J 2004; 68: 1023-1029.

50. Vasbinder GB, Nelemans PJ, Kessels AG et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135: 401-411.

51. Vasbinder GB, Nelemans PJ, Kessels AG et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004; 141: 674-682.

52. Vonken EP, Velthuis BK, Wittkampf FH et al. Contrast-enhanced MRA and 3D visualization of pulmonary venous anatomy to assist radiofrequency catheter ablation. J Cardiovasc Magn Reson 2003; 5: 545-551.

53. Welker M, Salanitri J, Deshpande VS et al. Coronary artery anomalies diagnosed by magnetic resonance angiography. Australas Radiol 2006; 50: 114-121.

54. Wisenberg G, Prato FS, Carroll SE et al. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J 1998; 115: 510-518.